€ millions | See Note | 2020 | 2019 |
Sales | 6 | 37,722.3 | 44,478.4 |
Cost of sales | -29,133.6 | -33,893.4 | |
Gross margin on sales | 8,588.7 | 10,585.0 | |
Research and development expenses | 7 | -4,330.6 | -4,471.8 |
Selling and logistics expenses | -2,417.3 | -2,718.9 | |
Administrative expenses | -1,156.9 | -1,110.2 | |
Other income | 8 | 1,711.2 | 1,774.6 |
Other expenses | 8 | -3,045.3 | -4,203.2 |
Income from equity-accounted investees | 10 | -68.5 | -124.3 |
Other income from investments | 10 | 0.6 | 0.5 |
EBIT | -718.1 | -268.3 | |
Interest income | 11 | 98.5 | 147.2 |
Interest expense | 11 | -282.2 | -317.3 |
Effects from currency translation | 11 | -97.4 | -30.5 |
Effects from changes in the fair value of derivative instruments, and other valuation effects | 11 | 69.1 | -119.7 |
Financial result | 11 | -212.0 | -320.3 |
Earnings before tax | -930.1 | -588.6 | |
Income tax expense | 12 | 11.3 | -582.4 |
Net income | -918.8 | -1,171.0 | |
Non-controlling interests | -43.1 | -54.0 | |
Net income attributable to the shareholders of the parent | -961.9 | -1,225.0 | |
Basic earnings per share in € | 38 | -4.81 | -6.13 |
Diluted earnings per share in € | 38 | -4.81 | -6.13 |